Infectious mononucleosis: Complexities of a common syndrome

Postgraduate Medicine

Volumn 107, Issue 7, 2000, Pages 175-186

  Godshall, Stephen E ^a   Kirchner, Jeffrey T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ANTIVIRUS AGENT; HETEROPHILE ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISOLONE;

ANTIBODY RESPONSE; ARTICLE; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; FATIGUE; FEVER; IMMUNOFLUORESCENCE TEST; INFECTIOUS MONONUCLEOSIS; LABORATORY TEST; LYMPHADENOPATHY; PHARYNGITIS; SPLEEN RUPTURE; SYNDROME; TREATMENT PLANNING; UPPER RESPIRATORY TRACT OBSTRUCTION;

EID: 0033948015     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.06.1130     Document Type: Article

References (34)

1. Kaye KM, Kieff E. Epstein-Barr virus infection and infectious mononucleosis. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. Philadelphia: Saunders, 1992:1646-54
2. Cheeseman SH. Infectious mononucleosis. Semin Hematol 1988;25(3):261-8
3. White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry 1998;173:475-81
4. Auwaerter PG. Infectious mononucleosis in middle age. JAMA 1999;281(5):454-9
5. Schooley RT. Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1364-77
6. Porter DD, Wimberly I, Benyesh-Melnick M. Prevalence of antibodies to EB virus and other herpesviruses. JAMA 1969;208(9):1675-9
7. Sawyer RN, Evans AS, Niederman JC, et al. Prospective studies of a group of Yale University freshmen: part I. Occurrence of infectious mononucleosis. J Infect Dis 1971; 123(3):263-70
8. Chang RS, Lewis JP, Abildgaard CF. Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med 1973; 289(25):1325-9
9. Murray BJ. Medical complications of infectious mononucleosis. Am Fam Physician 1984;30(5):195-9
10. Bonnet M, Guinebretiere JM, Kremmer E, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999;91(16):1376-81
11. Dommerby H, Stangerup SE, Stangerup M, et al. Hepatosplenomegaly in infectious mononucleosis, assessed by ultrasonic scanning. J Laryngol Otol 1986; 100(5):573-9
12. Linderholm M, Boman J, Juto P, et al. Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus - specific serology. J Clin Microbiol 1994;32(1):259-61
13. Evans AS, Niederman JC, Cenabre LC, et al. A prospective evaluation of hererophile and Epstein-Barr virus - specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody. J Infect Dis 1975;132(5):546-54
14. Sumaya CV, Ench Y. Epstein-Barr virus infectious mononucleosis in children: part II. Heterophil antibody and viral-specific responses. Pediatrics 1985;75(6): 1011-9
15. Sumaya CV, Ench Y. Epstein-Barr virus infectious mononucleosis in children: part I. Clinical and general laboratory findings. Pediatrics;1985:75(6):1003-10
16. Gerber MA. Treatment failures and carriers: perception or problems? Pediatr Infect Dis J 1994;13(6):576-9
17. Axelrod P, Finestone AJ. Infectious mononucleosis in older adults. Am Fam Physician 1990;42(6):1599-606
18. Bailey RE. Diagnosis and treatment of infectious mononucleosis. Am Fam Physician 1994;49(4):879-88
19. Bender CE. The value of corticosteroids in the treatment of infectious mononucleosis. JAMA 1967;199(8):529-31
20. Prout C, Dalrymple W. A double-blind study of eighty-two cases of infectious mononucleosis treated with corticosteroids. J Am Coll Health Assoc 1966;15(1):62-6
21. Klein E, Cochran JF, Buck RL. The effects of short-term corticosteroid therapy on the symptoms of infectious mononucleosis pharyngotonsillitis: a double-blind study. J Am Coll Health Assoc 1969;17(5): 446-52
22. Waldo RT. Neurologic complications of infectious mononucleosis after steroid therapy. South Med J 1981;74(9):1159-60
23. Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multi-center, double-blind, placebo-controlled study. J Infect Dis 1996;174(2):324-31
24. van der Horst C, Joncas J, Ahronheim G, et al. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 1991;164(4):788-92
25. Andersson J, Britton S, Ernberg I, et al. Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study. J Infect Dis 1986;153(2): 283-90
26. Kaplan JM, Keller MS, Troy S. Nasopharyngeal obstruction in infectious mononucleosis. Am Fam Physician 1987; 35(1):205-9
27. Farley DR, Zietlow SP, Bannon MP, et al. Spontaneous rupture of the spleen due to infectious mononucleosis. Mayo Clin Proc 1992;67(9):846-53
28. Maki DG, Reich RM. Infectious mononucleosis in the athlete: diagnosis, complications, and management. Am J Sports Med 1982;10(3):162-73
29. Purkiss SF. Splenic rupture and infectious mononucleosis - splenectomy, splenorrhaphy or non operative management? J R Soc Med 1992;85(8):458-9
30. National Center for Infectious Diseases. Screening tests for detecting common exclusionary conditions. Available at: http://www.cdc.gov/ncidod/diseases. Accessed Mar 20, 2000
31. Straus SE. The chronic mononucleosis syndrome. J Infect Dis 1988;157(3):405-12
32. Tobi M, Straus SE. Chronic mononucleosis - a legitimate diagnosis. Postgrad Med 1988;83(1):69-78
33. Berger RG, Raab-Traub N. Acute monoarthritis from infectious mononucleosis. Am J Med 1999;107(2):177-8
34. Cyran EM, Rowe JM, Bloom RE. Intravenous gammaglobulin treatment for immune thrombocytopenia associated with infectious mononucleosis. Am J Hematol 1991;38(2):124-9